More Monkeys With Edited Genomes

Researchers use the TALEN genome-editing technique to generate a primate model of Rett syndrome.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, ERIC BAJARTA female cynomolgus monkey born with mutations in her methyl-CpG binding protein 2 gene (MECP2) represents the first non-human primate model produced through transcription activator-like effector nucleases (TALENs), a gene-editing technique. The results, published February 13 in Cell Stem Cell, follow on the heels of a study demonstrating the ability of the CRISPR/Cas9 method to produce genomically edited monkeys.

Up until these two latest developments, transgenic monkeys had only come about through virus-mediated gene transfer. TALENs bind to and snip DNA at a specified point in the genome, allowing for targeted mutagenesis. In this case, researchers designed TALEN sequences to introduce mutations in MECP2 and delivered them into monkey zygotes. Several pregnancies failed, but one female monkey born with the mutations is now several months old.

Girls with Rett syndrome—which only affects females—develop motor and speech problems and autism-like characteristics. There is currently no cure. In the monkey, MECP2 mutations were present in the placenta, umbilical cord, and skin. “So far we have not observed any behavioral deficits in this female monkey,” the authors wrote in their report. The symptoms of Rett syndrome don’t ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies